Show simple item record

dc.contributor.authorWang, Wei
dc.date.accessioned2014-03-04T16:22:43Z
dc.date.available2014-03-04T16:22:43Z
dc.date.issued2008-12
dc.identifier.otherwang_wei_200812_ms
dc.identifier.urihttp://purl.galileo.usg.edu/uga_etd/wang_wei_200812_ms
dc.identifier.urihttp://hdl.handle.net/10724/25348
dc.description.abstractA biomarker is a detectable characteristic change resulting from a certain stimulus. The stimuli can be tumor growth, virus invasion, drug usage, etc. Biomarker discovery is essential for cancer diagnostics as well as treatment. Glycosylation is an important post-translational modification. Aberrant glycosylation has been hallmark of malignant transformation. Recently efforts have been made to correlate glycosylation pattern changes with cancer progression. In this review, we make an extensive study of possible mass spectrometry associated glycomics methods in finding cancer biomarkers in human serum. Established methods, such as glycoprotein enrichment, glycosylation site mapping, and glycan analysis are discussed and compared. New mass spectrometry methods, such as Ion Mobility Mass Spectrometry, Multiple Reaction Monitoring, Electron Transfer Dissociation are introduced.
dc.languageeng
dc.publisheruga
dc.rightspublic
dc.subjectcancer biomarker , serum, enrichment, glycosylation site mapping, Ion Mobility Mass Spectrometry, Multiple Reaction Monitoring
dc.titleCancer biomarker discovery
dc.title.alternativeglycomics study of human serum
dc.typeThesis
dc.description.degreeMS
dc.description.departmentChemistry
dc.description.majorChemistry
dc.description.advisorLance Wells
dc.description.committeeLance Wells
dc.description.committeeJonathan Amster
dc.description.committeeMichael Tiemeyer


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record